Prior view was $11.88-$12.08. FY25 consensus $11.97.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ABBV:
- AbbVie sees $1.50 per share unfavorable impact in Q3 from milestones expense
- AbbVie sees Q3 adjusted EPS $1.74-$1.78 with IPR&D, milestones expense
- Sector Spotlight: UnitedHealth shareholder proposes split of CEO, chair role
- AbbVie price target raised to $251 from $220 at BofA
- AbbVie’s Phase 2 HIV Study Completion: Potential Market Impact